U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192679) titled 'MAGNIFY - Pulmonary Magnetic Resonance Imaging for Cystic Fibrosis' on Sept. 04.
Brief Summary: This research study is looking at new ways of measuring the function of the lungs in patients with cystic fibrosis. This study is using the most advanced methods for measuring lung function including 2 tests called hyperpolarised gas magnetic resonance imaging (HP MRI) and multiple breath washout (MBW), to better understand changes in the lungs over time.
HP MRI involves taking pictures of the air in your lungs after breathing in a harmless gas (xenon). MBW is a breathing test used to calculate something called the lung clearance index ...